Latest available resultsQuarter ended June 30, 202610-Q · July 28, 2026
Filed with the SECCENTENE CORP
CNCHealthcare
Next reportOctober 27, 2026pre-market · Analyst forecast 0.103 $/share
Revenue
$53.58B
▲ +9.9% vs prior year% YoY
Net income
$1.09B
▲ +531.2% vs prior year% YoY
EPS
2.19$
▲ +529.4% vs prior year% YoY
Net margin
2.0%
▲ +2.6 percentage points vs prior year pp YoY
Revenue▲ +9.9 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +531.2 %
EPS▲ +529.4 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $53.58B | |
| Gross profit | $4.62B | 8.6 % |
| Operating income | $1.20B | 2.2 % |
| Net income | $1.09B | 2.0 % |
| R&D | — | never filed |
| EPS (diluted) | 2.19 $ | |
| Balance sheet | ||
| Assets | $83.01B | |
| Liabilities | $60.35B | |
| Equity | $22.63B | |
| Cash | $24.15B | |
| Capital | ||
| Shares outstanding | 494.00M | as of 2026-07-24 |
| Public float | — | |